|
EIF1AD expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.77880000000431E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.89409999999635E-05 |
| Normal-vs-Stage2 |
2.814400E-02 |
| Normal-vs-Stage3 |
1.821660E-02 |
| Normal-vs-Stage4 |
1.281510E-03 |
| Stage1-vs-Stage2 |
6.797200E-01 |
| Stage1-vs-Stage3 |
2.342200E-01 |
| Stage1-vs-Stage4 |
6.474400E-01 |
| Stage2-vs-Stage3 |
6.712800E-01 |
| Stage2-vs-Stage4 |
4.842000E-01 |
| Stage3-vs-Stage4 |
1.972820E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.96500999999349E-05 |
| Normal-vs-AfricanAmerican |
2.519000E-01 |
| Normal-vs-Asian |
2.21759999999849E-05 |
| Caucasian-vs-AfricanAmerican |
1.544990E-01 |
| Caucasian-vs-Asian |
2.515800E-01 |
| AfricanAmerican-vs-Asian |
2.234000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.630500E-04 |
| Normal-vs-Female |
1.794450E-04 |
| Male-vs-Female |
9.077200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.72890999999842E-05 |
| Normal-vs-Age(41-60Yrs) |
5.169300E-04 |
| Normal-vs-Age(61-80Yrs) |
9.831700E-02 |
| Normal-vs-Age(81-100Yrs) |
5.363000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.998200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.493700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.175700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.281050E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.300830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.556200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.814800E-01 |
| Classical-VS-Follicular |
7.67590435657439E-11 |
| Classical-VS-Other |
5.967600E-01 |
| Classical-VS-Normal |
8.46030000500875E-08 |
| Tall-VS-Follicular |
4.520100E-03 |
| Tall-VS-Other |
9.828800E-01 |
| Tall-VS-Normal |
7.801000E-03 |
| Follicular-VS-Other |
1.261450E-01 |
| Follicular-VS-Normal |
4.156600E-01 |
| Other-VS-Normal |
1.153000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.679000E-03 |
| Normal-vs-N1 |
2.460500E-03 |
| N0-vs-N1 |
2.600800E-01 |
|
|
